Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13

SAN DIEGO, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced that it will host a conference call and live webcast on Thursday, August 13, 2020 at 4:30 p.m. Eastern Time to report financial results for its second quarter ended June 30, 2020 and provide a business update. Among the highlights the company plans to cover is an update regarding the approximately $14 million in cash proceeds the company received pursuant to warrant exercises since the end of the second quarter. Accordingly, the company believes that its current cash and cash equivalents are sufficient to fund the company's operations into the first quarter of 2021.

Conference Call & Webcast Details
Date:	Thursday August 13th
Time:	4:30 p.m. Eastern Time
Toll Free:	877-407-0784
International:	201-689-8560
Conference ID:	13706933
Webcast:	http://public.viavid.com/index.php?id=140743

To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay in the Investors section of the Bionano website.

About Bionano Genomics
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Bionano's Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. For more information, visit www.bionanogenomics.com.